vaccine Archive — Page 2 of 3
-
April 7, 2014
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
-
January 15, 2014
HIV’s impact on B cells
Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development. -
August 15, 2013
Flulapalooza vaccination event set for Sept. 25
Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period. -
May 30, 2013
Study lays groundwork for rational T cell vaccine design
Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response. -
November 12, 2012
UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals. -
October 31, 2012
Protein’s length, flexibility key to infection
The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells. -
October 10, 2012
Additional volunteers needed for Flulapalooza Oct. 17 and 18